Acute Myeloid Leukemia Clinical Trials in Beijing
7 recruitingBeijing, China
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemias
Janssen Research & Development, LLC400 enrolled101 locationsNCT04811560
Recruiting
Phase 2
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Acute Myeloid LeukemiaLeukemia
Daiichi Sankyo130 enrolled58 locationsNCT06824168
Recruiting
Phase 2
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Acute Myeloid Leukemia
Beijing 302 Hospital50 enrolled1 locationNCT07078591
Recruiting
Phase 1
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromeB-cell Lymphoma
NovaOnco Therapeutics Co., Ltd.168 enrolled4 locationsNCT06820268
Recruiting
Phase 2
Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
AMLRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
Beijing 302 Hospital20 enrolled1 locationNCT06741722
Recruiting
Phase 2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Acute Myeloid LeukemiaAML, Childhood
Children's Hospital of Soochow University500 enrolled13 locationsNCT06221683
Recruiting
Not Applicable
MRD Response-adapted Allo-HSCT for Adverse-risk AML
Acute Myeloid Leukemia
Peking University People's Hospital178 enrolled1 locationNCT06301425